CLEMENTIA PHARMACEUTICALS IN's ticker is CMTA and the CUSIP is 185575107. A total of 1 filers reported holding CLEMENTIA PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $17,811,000 | +499.3% | 682,400 | +202.1% | 0.24% | +770.4% |
| Q2 2018 | $2,972,000 | +15.6% | 225,862 | +33.1% | 0.03% | +28.6% |
| Q1 2018 | $2,571,000 | +69.4% | 169,670 | +112.1% | 0.02% | +75.0% |
| Q4 2017 | $1,518,000 | +12.4% | 80,000 | 0.0% | 0.01% | +20.0% |
| Q3 2017 | $1,351,000 | – | 80,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,425,225 | $176,082,000 | 1.68% |
| NEA Management Company, LLC | 2,141,697 | $36,173,000 | 1.27% |
| RA Capital Management | 585,403 | $9,887,000 | 0.89% |
| DAFNA Capital Management LLC | 60,000 | $1,013,000 | 0.63% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 819,508 | $13,841,000 | 0.54% |
| EcoR1 Capital, LLC | 194,166 | $3,279,000 | 0.44% |
| SPHERA FUNDS MANAGEMENT LTD. | 163,000 | $2,753,000 | 0.39% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 462,387 | $7,810,000 | 0.35% |
| Rock Springs Capital Management LP | 345,000 | $5,827,000 | 0.27% |
| Perceptive Advisors | 704,500 | $12,582,000 | 0.24% |